ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | +92.9% | 12,179 | +60.8% | 0.00% | – |
| Q1 2022 | $14,000 | -22.2% | 7,575 | +42.7% | 0.00% | – |
| Q3 2021 | $18,000 | – | 5,310 | +5055.3% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 103 | -71.7% | 0.00% | – |
| Q4 2020 | $1,000 | -75.0% | 364 | -82.4% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 2,065 | +28.7% | 0.00% | – |
| Q2 2020 | $5,000 | +400.0% | 1,604 | +500.7% | 0.00% | – |
| Q1 2020 | $1,000 | -93.3% | 267 | -91.0% | 0.00% | – |
| Q4 2019 | $15,000 | +25.0% | 2,983 | +46.4% | 0.00% | – |
| Q3 2019 | $12,000 | +300.0% | 2,037 | +307.4% | 0.00% | – |
| Q2 2019 | $3,000 | -86.4% | 500 | -84.9% | 0.00% | – |
| Q1 2019 | $22,000 | -8.3% | 3,317 | -43.3% | 0.00% | – |
| Q4 2018 | $24,000 | +41.2% | 5,851 | +280.2% | 0.00% | – |
| Q3 2018 | $17,000 | – | 1,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,349,953 | $8,046,000 | 2.52% |
| Novo Holdings A/S | 2,181,843 | $13,004,000 | 2.23% |
| Sofinnova Investments, Inc. | 1,180,178 | $7,034,000 | 0.64% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,041,496 | $12,168,000 | 0.09% |
| Eventide Asset Management | 392,513 | $2,288,000 | 0.08% |
| Blackstone Inc. | 1,623,405 | $9,675,000 | 0.06% |
| Granahan Investment Management | 141,012 | $840,000 | 0.05% |
| Janney Montgomery Scott LLC | 46,861 | $279,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,921 | $35,000 | 0.00% |
| BlackRock Inc. | 15,755 | $94,000 | 0.00% |